[Rhinitis therapy. Experiences with triprolidine hydrochloride/pseudoephedrin hydrochloride, a decongestive and antiallergic therapeutic agent].
63 patients were treated with the combination of pseudoephedrine hydrochloride and triprolidine hydrochloride (Actifed). Indications were infectious, allergic and vasomotoric rhinitis. The 63 patients divided in 32 children in the age of 2 to 12 years and 31 adults in the age of 14 to 56 years. The daily dose range depending on age was 90.0 to 180.0 mg pseudoephedrine hydrochloride and 3.75 to 7.5 mg triprolidine hydrochloride, applicated either as syrup or as tablets. All patients accepted the drug well. In 58 cases the effect of the drug for treatment of common cold was very good and good. Side-effects were not observed, apart from tiredness in 18 cases, which--however--did only occur at the first day of treatment.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations / Q000494:pharmacology / Q000627:therapeutic use; D004809:Ephedrine / Q000494:pharmacology / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D054199:Pseudoephedrine; D011725:Pyridines / Q000627:therapeutic use*; D012220:Rhinitis / Q000188:drug therapy*; D014311:Triprolidine / Q000494:pharmacology / Q000627:therapeutic use*
D004338:Drug Combinations; D006634:Histamine H1 Antagonists; D011725:Pyridines; C006399:pseudoephedrine, triprolidine drug combination; D014311:Triprolidine; D054199:Pseudoephedrine; D004809:Ephedrine
Rhinitis-Therapie. Erfahrungen mit Triprolidinhydrochlorid/Pseudoephedrinhydrochlorid, einem schleimhautabschwellenden und antiallergisch wirkenden Therapeutikum.